source
- Doctors question Boston Scientific's Watchman marketing after FDA approvalBoston Scientific's Watchman cardiac implant has been placed in more than 800,000 patients worldwide. The device eventually secured FDA approval after a protracted review, but the clearance was li…
- Windward Bio raises $175M in IPO, boosting 2026 biotech debut count to 35Windward Bio completed an initial public offering that raised about $175 million, selling roughly 10.3 million shares at $17 each on the Nasdaq. The proceeds are earmarked to advance its lead antib…